Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Retrieved from Novo Nordisk-e
GLP-1 drugs linked to reduced risk of epilepsy A retrospective analysis of data from adults treated for type-2 diabetes indicates that glucose-lowering GLP-1 drugs could be linked to a lower risk of epilepsy
Important Considerations for Long-Term Weight Management Medical Supervision: Regular check-ups monitor progress and address concerns
However, GLP-1RAs should be considered as the preferential add-on therapy in T2DM patients with CKD in case of persistent albuminuria and/or uncontrolled metabolic risks (i.e., inadequate glycemic control, hypertension, overweight/obesity)
DalleCOstermannAIKonradTCoudy-GandilhonCDecourtABarthlmyJ-Cet al
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: an 8-month prospective study
US$ 28.98
US$ 26.98
US$ 22.03
US$ 25.16
US$ 26.37
US$ 21.78
US$ 25.88
US$ 27.33
US$ 24.61
US$ 26.19
US$ 22.55
